Neurolepsin (Lithium Carbonate)

Lithium carbonate, the active ingredient in Neurolepsin, is a mood stabilizer presented as an oral tablet for oral use. It is employed in the management of bipolar disorder, helping to stabilize mood and reduce the frequency of manic and depressive episodes. Its pharmacological profile includes modulation of intracellular signaling pathways, which contributes to its therapeutic effect.

GNH USA supplies Neurolepsin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export to multiple regions. Clients benefit from reliable logistics, batch traceability, and dedicated technical support throughout the procurement process.

Neurolepsin, a lithium carbonate formulation, acts on mood regulation pathways in bipolar disorder.

- Bipolar disorder (maintenance therapy): maintains mood stability and reduces recurrence of manic and depressive episodes. - Acute manic episodes: rapidly diminishes manic symptoms such as elevated mood, hyperactivity, and irritability. - Schizoaffective disorder (bipolar type): helps control mood swings and stabilizes affective symptoms.

Lithium carbonate may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Tremor: fine, usually reversible hand tremor. - Increased thirst and urination: polyuria and polydipsia. - Nausea or mild gastrointestinal upset: occasional nausea, abdominal discomfort. - Weight gain: modest increase in body weight over time.

Serious or Rare Side Effects: - Lithium toxicity: confusion, seizures, or coma at high serum levels. - Renal impairment: reduced kidney function with long‑term use. - Thyroid dysfunction: hypothyroidism requiring hormone replacement.

When prescribing Neurolepsin, clinicians should observe several safety measures to minimize risk.

- Serum level monitoring: regular measurement of lithium concentrations to stay within therapeutic range. - Renal function assessment: evaluate kidney function before initiation and periodically thereafter. - Thyroid function evaluation: check thyroid hormones at baseline and during treatment. - Hydration status: maintain adequate fluid intake and avoid dehydration. - Pregnancy considerations: use only if potential benefit justifies unknown fetal risk. - Store at room temperature: keep in original packaging, protect from moisture and light.

Lithium carbonate interacts with several drug classes, requiring careful management.

Major Interactions (Avoid): - NSAIDs: can raise lithium serum levels and increase toxicity risk. - Thiazide diuretics: reduce renal clearance of lithium, leading to accumulation. - ACE inhibitors or ARBs: may potentiate lithium effects and precipitate toxicity.

Moderate Interactions (Monitor Closely): - SSRIs: combined use may increase risk of serotonin syndrome. - Carbamazepine: may lower lithium concentrations, reducing efficacy.